CDH1 and ovarian carcinoma: The aim of this study was to determine the expression of β-catenin, E-cadherin and WNT-1 in advanced epithelial ovarian cancers and to assess the correlation of expression of the studied proteins with patient survival and response to platinum-based chemotherapy.